Family Wealth Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
Family Wealth Partners's BMY Position: Q2 2026 in Review
Family Wealth Partners reduced its Bristol-Myers Squibb (BMY) stake by 17% in Q2 2026, selling an estimated $76.9K and leaving 6,383 shares worth $368K. The position accounts for 0.11% of the portfolio, ranked #71.
Family Wealth Partners first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $468K in Q1 2026. 1,158 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Family Wealth Partners held 6,383 shares of Bristol-Myers Squibb worth $368K as of Q2 2026.
- Family Wealth Partners sold 1,340 Bristol-Myers Squibb shares in Q2 2026, an estimated $76.9K.
- Bristol-Myers Squibb made up 0.11% of Family Wealth Partners's portfolio in Q2 2026, its #71 holding.
- Family Wealth Partners first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
- Family Wealth Partners's Bristol-Myers Squibb position peaked at $468K in Q1 2026.
- 1,158 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Family Wealth Partners's 13F filing for Q2 2026, filed 10 Jul 2026.